Author： Haut Sheryl R. Bienen E. Jay Miller Aaron
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.11, Iss.4, 2012-07, pp. : 651-657
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Overview of Seizure-Inducing Potential of Doripenem
Drug Safety, Vol. 32, Iss. 9, 2009-09 ,pp. :
Access to resources
Recommend
Overview of the Clinical Pharmacokinetics of Oxcarbazepine
By Flesch G.
Clinical Drug Investigation, Vol. 24, Iss. 4, 2004-01 ,pp. :
Susceptibility and risk: an overview
Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. :
Dalfampridine Extended Release: In Multiple Sclerosis
By Chwieduk Claudine M. Keating Gillian M.
CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. :
Overview of Health Risk Assessments for Zinc
Journal of Toxicology and Environmental Health, Vol. 73, Iss. 2-3, 2010-01 ,pp. :